학술논문
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD® ) in Asian men with prostate cancer
Document Type
Article
Author
Source
In: Translational Andrology and Urology . (Translational Andrology and Urology, February 2022, 11(2):179-189)
Subject
Language
English
ISSN
22234691
22234683
22234683